Competition Between Kidney Cancer Producers to Intensify Further, Expansion of Distribution Networks to Play Catalyst, Reports TMR
With intensifying competition in the global kidney cancer drugs market, key players are focusing on enhancing their product portfolio, finds a recent study by Transparency Market Research (TMR). In 2013, the top three players, namely, Novartis AG, Pfizer Inc., and Bayer AG, collectively accounted for a share of more than 80% in this highly consolidated market.
View full press release